TTK Healthcare Q1 FY27 Results: Revenue Rs 257 Cr, PAT Rs 21 Cr and Key Highlights

TTK Healthcare Q1 FY27 results were announced on August 6, 2026, on a Standalone basis. TTK Healthcare Q1 FY27 results show revenue grew +13.75% year-on-year to Rs 257 Cr from Rs 226 Cr in Q1 FY26, reflecting sustained demand in the Healthcare segment. The broader BSE Healthcare index also reflected mixed sentiment during the quarter.

Operating profit improved +2483.55% YoY to Rs 12 Cr from Rs 0 Cr, indicating stronger operational efficiency. PAT grew strongly +63.69% YoY to Rs 21.00 Cr from Rs 12.00 Cr in Q1 FY26. The quarterly numbers offer a detailed picture of how the company is navigating the current healthcare environment.

Click Here – Get Free Investment Predictions

TTK Healthcare Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Cr)	Q1 FY26 (Rs Cr)	YoY Change
TTK Healthcare Revenue	257	226	+13.75%
Operating Profit	12	0	+2483.55%
Net Profit (PAT)	21	12	+63.69%
Reporting Basis	Standalone

TTK Healthcare Q1 FY27 Performance Analysis

Check the Univest Screener for Live Data on This Stock

TTK Healthcare Q1 FY27 results reflect strong fundamentals across key financial parameters. Revenue momentum continued on a strong footing with the top line reaching Rs 257 Cr for the April to June 2026 quarter.

Operating profit stood at Rs 12 Cr, expanding +2483.55% YoY. Margin improvement signals better cost absorption and product mix optimisation.

PAT of Rs 21 Cr marks a +63.69% year-on-year improvement. Investors monitoring TTK Healthcare Q1 FY27 results will note this as a key milestone for FY27 tracking.

Key Business Factors in TTK Healthcare Q1 FY27 Results

Revenue Growth Momentum in the Healthcare Segment

TTK Healthcare Q1 FY27 results demonstrate consistent top-line expansion, with revenue rising +13.75% YoY to Rs 257 Cr. Volume-led growth and pricing discipline in key markets drove the uptick.

Operating Margin Expansion Signals Efficiency Gains

Operating profit in TTK Healthcare Q1 FY27 results rose +2483.55% YoY to Rs 12 Cr. This reflects tighter cost control, better product mix, and operating leverage as the company scales volumes in core business lines.

PAT Performance and Profitability Trend

Net profit in TTK Healthcare Q1 FY27 results stood at Rs 21 Cr (+63.69% YoY). The sustained PAT growth reflects the company's improving financial profile.

Dividend Details

No dividend was announced along with TTK Healthcare Q1 FY27 results. The company is likely retaining earnings for reinvestment into growth capex and working capital requirements.

FY27 Outlook for TTK Healthcare

TTK Healthcare is positioned to maintain growth momentum into Q2 FY27 and beyond, supported by order visibility, operational improvements, and sector tailwinds. Management guidance points toward continued expansion in the Healthcare business with a focus on margin improvement and market share consolidation. Investors tracking TTK Healthcare Q1 FY27 results are advised to consult a SEBI-registered financial advisor before making decisions.

TTK Healthcare Stock Performance After Q1 FY27 Results

Download the Univest iOS App or Univest Android App to track TTK Healthcare live price and get daily stock recommendations.

TTK Healthcare shares were trading higher at Rs 1094.1 (+4.61%) on August 6, 2026, following the declaration of TTK Healthcare Q1 FY27 results. The stock reaction reflects investor sentiment on near-term earnings trajectory and sector outlook. CMP stood at Rs 1094.1 on the results date, with a 52-week range reflecting the broader market sentiment toward the healthcare sector.

Key Risks for TTK Healthcare

Sector-Specific Headwinds

Rising operational costs, competition from hospital chains, and insurance penetration risks could limit upside.

Valuation and Earnings Risk

Valuation risk remains if earnings growth fails to sustain at current levels over the next two to three quarters.

Operational and Financial Risk

Working capital intensity and cash conversion cycle elongation pose risks to standalone cash flows.

Conclusion

TTK Healthcare Q1 FY27 results demonstrate strong financial performance with revenue at Rs 257 Cr and PAT at Rs 21 Cr on a Standalone basis. Operating leverage and disciplined cost management will be key drivers for the rest of FY27. Investors should track upcoming management commentary on growth drivers and sector developments before taking positions.

Frequently Asked Questions on TTK Healthcare Q1 FY27 Results

When were TTK Healthcare Q1 FY27 results declared?

Ans. TTK Healthcare Q1 FY27 results were declared on August 6, 2026. The results cover the April to June 2026 quarter on a Standalone basis.

What was TTK Healthcare revenue in Q1 FY27?

Ans. TTK Healthcare Q1 FY27 results show revenue of Rs 257 Cr, +13.75% compared to Rs 226 Cr in Q1 FY26.

What was TTK Healthcare PAT in Q1 FY27?

Ans. Net profit (PAT) in TTK Healthcare Q1 FY27 results was Rs 21 Cr, +63.69% year-on-year.

Did TTK Healthcare declare a dividend in Q1 FY27?

Ans. No dividend was declared alongside TTK Healthcare Q1 FY27 results. Investors should check the official company announcements on BSE and NSE for any future dividend declarations.

What is the FY27 outlook for TTK Healthcare?

Ans. TTK Healthcare management has outlined a focus on revenue scaling and margin improvement for the remainder of FY27. Sector tailwinds and order book visibility will be key monitorables.

How did the TTK Healthcare stock react to Q1 FY27 results?

Ans. TTK Healthcare shares were trading higher at Rs 1094.1 (+4.61%) on August 6, 2026, following the TTK Healthcare Q1 FY27 results announcement. Investors should consult a SEBI-registered financial advisor before acting on price movements.